Ru(II) Complexes with Absorption in the Photodynamic Therapy Window: O Sensitization, DNA Binding, and Plasmid DNA Photocleavage.

Two Ru(II) complexes, [Ru(pydppn)(bim)(py)] [; pydppn = 3-(pyrid-2'-yl)-4,5,9,16-tetraaza-dibenzo[]naphthacene; bim = 2,2'-bisimidazole; py = pyridine] and [Ru(pydppn)(Mebim)(py)] [; Mebim = 2,2'-bis(4,5-dimethylimidazole)], were synthesized and characterized, and their photophysical properties, DNA binding, and photocleavage were evaluated and compared to [Ru(pydppn)(bpy)(py)] (; bpy = 2,2'-bipyridine). Complexes and exhibit broad MLCT (metal-to-ligand charge transfer) transitions with maxima at ∼470 nm and shoulders at ∼525 and ∼600 nm that extend to ∼800 nm. These bands are red-shifted relative to those of , attributed to the π-donating ability of the bim and Mebim ligands. A strong signal at 550 nm is observed in the transient absorption spectra of -, previously assigned as arising from a pydppn-centered ππ* state, with lifetimes of ∼19 μs for and and ∼270 ns for . A number of methods were used to characterize the mode of binding of - to DNA, including absorption titrations, thermal denaturation, relative viscosity changes, and circular dichroism, all of which point to the intercalation of the pydpppn ligand between the nucleobases. The photocleavage of plasmid pUC19 DNA was observed upon the irradiation of - with visible and red light, attributed to the sensitized generation of O by the complexes. These findings indicate that the bim ligand, together with pydppn, serves to shift the absorption of Ru(II) complexes to the photodynamic therapy window, 600-900 nm, and also extend the excited state lifetimes for the efficient production of cytotoxic singlet oxygen.